En
No administrar benzodiacepinas de vida media larga para el tratamiento crónico del insomnio, en personas mayores de 65 años.
Año: 2016
Sociedad Científica: Sociedad Española de Psiquiatría (SEP)
Áreas Clínicas: Salud Mental
Áreas Temáticas: Insomnio
Más información:

Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs (2003);17:825-837.

Jacobson SA, Pies RW, Katz IR[Eds] Clinical Manual of Geriatric Psychopharmacology. America Psychiatric Publihing Inc.Washington DC, 2007.

Ohyon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews 2002;6(2):97-111.

Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000;48:682-685.

Sivertsen B, Krokstad S,Overlandd S, Mykletun A. The epidemiology of insomnia: Associations with physical and mental health. The HUNT-2 Study. J Psychosom Research 2009;67:109-116.

Smith AJ, Tett SE. Improving the use of benzodiazepines- Is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Services Research 2010;10:321.

Vinkers DJ, Gussekloo J, Van der Mast RC et al. Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003;290:2942-2943.